Stockreport

Invivyd: Why I'm Selling The CDTX Read-Through Rally [Seeking Alpha]

Invivyd, Inc.  (IVVD) 
PDF VYD2311 targets COVID-19 with a long-acting mAb but faces rapid viral evolution, a shrinking market, and political headwinds, unlike CD388's flu opportunity. IVVD's f [Read more]